Clinical trial
Targeted Testing for Transthyretin Cardiac Amyloid Among Aortic Stenosis Patients-Pilot
NCT04363294 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeted Testing for Transthyretin Cardiac Amyloid Among Aortic Stenosis Patients-Pilot
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- March 31, 2022
- Completion date
- August 31, 2023
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
aortic valve stenosis, cardiac amyloidosis